Early Extubation and Postoperative Complications After Liver Transplantation
- Conditions
- Liver Transplantation
- Interventions
- Procedure: extubation in the ICUProcedure: extubation in the operating room
- Registration Number
- NCT04261816
- Lead Sponsor
- West China Hospital
- Brief Summary
This is a retrospective cohort study. Patients who underwent liver transplantation from January 1, 2016 to December 31, 2019 were admitted to the study and divided into two groups. Operating room extubation group: early extubation in the operating room immediately following liver transplantation. Intensive care unit (ICU) extubation group: delay extubation in the ICU following liver transplantation. The primary objectives were to compare the incidence of composite outcome between the two groups. secondary objectives were to compare outcomes such as length of stay, hospital length of stay, and total cost between the two groups.
- Detailed Description
Patients who underwent liver transplantation from January 1, 2016 to December 31, 2019 were admitted to the study. Inclusion criteria: (1) adult patients (age ≥ 18 years), (2) undergoing liver transplantation. Exclusion criteria were the following: (1) re-transplantation; (2) multi-visceral transplantation; (3) intraoperative death; (4) severe encephalopathy (West Haven criteria III or IV); (5) those who had preoperative mechanical ventilation; (6) incomplete clinical data. The primary objectives was a composite of 30-day all-cause mortality, in-hospital AKI, or in-hospital moderate to severe pulmonary complications. Complications were defined and graded as mild, moderate, or severe as described by European Perioperative Clinical Outcome definitions and were included if they occurred in hospital after surgery. The secondary objectives included in-hospital moderate to severe infectious complications, unplanned reintubation rates, ICU and postoperative hospital lengths of stay, and total hospital cost.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 438
- Adult patients (age ≥ 18 years)
- Undergoing liver transplantation
- Re-transplantation
- Multi-organ transplants
- Intra-operative deaths
- severe encephalopathy (West Haven criteria III or IV)
- patients who had preoperative mechanical ventilation or fulminant hepatic failure
- Incomplete clinical data
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description ICU extubation group extubation in the ICU extubation in the ICU following liver transplantation Operating room extubation group extubation in the operating room extubation in the operating room immediately following liver transplantation
- Primary Outcome Measures
Name Time Method The incidence of a composite of 30-day all-cause mortality, AKI and moderate to severe pulmonary complications. through study completion, an average of 1 year Complications were defined and graded as mild, moderate, or severe as described by European Perioperative Clinical Outcome definitions and were included if they occurred in hospital after surgery
- Secondary Outcome Measures
Name Time Method The incidence of moderate to severe infectious complications 30 days Complications were defined and graded as mild, moderate, or severe as described by European Perioperative Clinical Outcome definitions and were included if they occurred in hospital after surgery
The length of ICU stay through study completion, an average of 1 year Length of ICU stay is the duration of a single episode of ICU hospitalization
The incidence of re-intubation. 30 days Reintubation was defined as intubation after extubation of a patient who had been initially tracheal intubated under general anaesthesia
The length of hospital stay through study completion, an average of 1 year Length of hospital stay is the duration of a single episode of hospitalization
The total hospital cost 30 days The total hospital cost
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
West China Hospital
🇨🇳Chengdu, Sichuan, China